• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Natco Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco
  • BSE Code : 4684.0
  • ISIN : INE987B01026
798.75 -24 (-2.92%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    795.00

  • Today’s High

    834.95

  • Open

    822.85

  • Perv Close

    822.75

  • 52W Low

    757.05

  • 52W High

    1,639.00

Key Indicators

  • P/E(TTM)

    8.07

  • Mar.Cap (₹Cr.)

    14,306.40

  • Div & Yield %

    1.19

  • Book Value(₹)

    382.03

  • Debt-Equity Ratio

    -2.92

  • AGM Date

    28-Mar-2025

  • EPS

    98.90

  • P/E Ratio

    8.07

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    14,306.40

  • RONW (%)

    25.88

  • ROCE (%)

    29.63

Score Board

  • Equity (₹ in Cr.)

    35.82

  • BV (₹)

    382.00

  • Sales( ₹ in Cr.)

    3,568.90

  • NP (in Cr.)

    1,308.72

  • NP Var(%)

    110.0

  • Div%

    475.0

  • CPS (₹)

    82.70

  • EPS (₹)

    73.10

  • Traded Value (₹ in Lakhs)

    14,287.59

  • 52 Week High

    1,639.00

  • 52 Week Low

    757.05

  • Price BSE

    798.0

  • Price NSE

    799.00

  • Market Capital( in Cr.)

    14,287.59

  • P/C Ratio

    9.70

  • P/E Ratio

    10.90

  • Price Vs.BV

    73.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Excise Duty 3,194.70 2,268.20 1,532.30 1,602.40 1,587.70 1,931.70
Net Sales 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30
Other Income 104.70 85.50 94.60 101.10 123.80 129.80
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 3,673.60 2,436.50 1,862.40 1,754.60 1,914.00 2,116.10
EXPENDITURE :
Raw Materials 3,194.70 2,268.20 1,532.30 1,602.40 1,587.70 1,931.70
Power & Fuel Cost 3,194.70 2,268.20 1,532.30 1,602.40 1,587.70 1,931.70
Employee Cost 454.90 425.70 410.10 380.00 356.10 340.20
Other Manufacturing Expenses 150.10 28.00 75.90 41.90 59.70 57.50
Selling & Administrative Expenses 489.00 298.30 317.50 146.90 210.10 260.80
Miscellaneous Expenses 150.10 28.00 75.90 41.90 59.70 57.50
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,118.30 1,665.80 1,706.50 1,362.40 1,330.90 1,268.70
Operating Profit 263.40 224.60 216.70 167.10 189.30 172.20
Interest 14.50 8.60 13.30 11.30 20.60 18.80
Gross Profit 1,555.30 770.70 155.90 392.20 583.10 847.40
Depreciation 171.90 150.90 138.40 115.20 98.10 80.10
Profit Before Tax 1,555.30 770.70 155.90 392.20 583.10 847.40
Tax 284.80 133.10 32.50 93.30 129.10 186.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -36.10 0.50 -15.70 -10.60 -20.50 -6.00
Reported Net Profit 1,306.60 637.10 139.10 309.50 474.50 667.10
Extraordinary Items 1,555.30 770.70 155.90 392.20 583.10 847.40
Adjusted Net Profit 1,306.60 637.10 139.10 309.50 474.50 667.10
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 170.15 100.36 82.10 95.65 122.90 114.60
P & L Balance carried down 1,306.60 637.10 139.10 309.50 474.50 667.10
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 475.00 275.00 225.00 262.50 337.50 312.50
Dividend Per Share(Rs) 9.50 5.50 4.50 5.25 6.75 6.25
Earnings Per Share-Unit Curr 72.79 34.90 7.63 16.99 26.08 36.22
Book Value 170.15 100.36 82.10 95.65 122.90 114.60
Book Value(Adj)-Unit Curr 170.15 100.36 82.10 95.65 122.90 114.60

Shareholding Pattern

  • Promoter Group

    49.62%

  • Public Share Holding

    50.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 33,070,070 18.46 33,070,070 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,114,055 28.54 51,114,055 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,686,150 2.62 4,686,150 4
Others 0 0.00 0 0
Sub Total 88,870,275 49.62 88,870,275 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 25 0.00 25 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 32,125,686 17.94 32,125,686 351
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,957,211 3.33 5,957,211 12
Mutual Funds / UTI 3,432,444 1.92 3,432,444 51
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 595,402 0.33 595,402 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 42,110,768 23.51 42,110,768 435
2] Non Institution
Bodies Corporate 2,857,185 1.60 2,841,585 1,291
Clearing Members 9,150 0.01 9,150 12
Directors of their Relatives 119,923 0.07 119,923 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,458,090 1.37 2,456,990 8,562
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,574,399 3.67 6,574,399 24
Individuals holding nominal share capital up to Rs. 1 lakh 35,228,893 19.67 34,835,603 334,966
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 13,805 0.01 13,805 9
Others 867,382 0.48 867,382 3
Sub Total 48,128,827 26.87 47,718,837 344,876
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 179,109,870 100.00 178,699,880 345,332

Company Background

Natco Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Natco Pharma Ltd
  • BSE Code : 4684.0
  • ISIN : INE987B01026

  • Incorporation Year

    1981

  • Registered Office

    Natco House
    Road No 2 Banjara Hills, Hyderabad,
    Telangana-500033

  • Telephone

    91-040-23547532

  • FAX

    91-040-23548243

  • Chairman

    V C Nannapaneni

  • Managing Director

    V C Nannapaneni

  • Company Secretary

    Venkat Ramesh

  • Auditor

    B S R & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Natco Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Natco Pharma 797.70 3,673.60 3,568.90 8.07 28.58
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92